Dr. Lakkireddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10500 Quivira Rd
Overland Park, KS 66215
Summary
- Dr. Dhanunjaya Lakkireddy is a board-certified, fellowship-trained cardiologist specializing in electrophysiology and the Medical Director for the Kansas City Heart Rhythm Institute at HCA Midwest Health. Dr. Lakkireddy is affiliated with the HCA Midwest Health network of hospitals located throughout the Kansas City, Mo and Overland Park, Kan. metro areas. With more than 15 years of experience, he has specialized clinical expertise and interests in electrophysiology, complex arrhythmia management (atrial fibrillation, atrial flutter, ventricular tachycardia, supraventricular tachycardia), heart ablation, left atrial appendage closure; ablation, pacemaker and other device implantation and management, cardiac resynchronization therapy& pulmonary artery pressure sensors in heart failure, premature ventricular contractions, syncope, adult congenital and inherited cardiac rhythm disorders (Long QT, hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, Brugada syndrome) and myocarditis.
Education & Training
- Cleveland Clinic FoundationFellowship, Clinical Cardiac Electrophysiology, 2005 - 2006
- Creighton University School of Medicine (Omaha)Fellowship, Cardiovascular Disease, 2002 - 2005
- University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1998 - 2001
- Osmania Medical College NTR UHSClass of 1996, Graduate Degree
Certifications & Licensure
- AZ State Medical License 2010 - 2025
- KS State Medical License 2001 - 2025
- MO State Medical License 2006 - 2025
- LA State Medical License 2021 - 2024
- TX State Medical License 2022 - 2022
- MI State Medical License 2001 - 2020
- NY State Medical License 2016 - 2019
- Join now to see all
Clinical Trials
- AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study) Start of enrollment: 2021 Dec 29
Roles: Principal Investigator, Contact
- AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US) Start of enrollment: 2020 Sep 29
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.Dhanunjaya Lakkireddy, Christopher R Ellis, David Thaler, Vijendra Swarup, Alok Gambhir
Journal of the American College of Cardiology. 2024-11-15 - 232 citationsLeft atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysisAugustine Njoku, Munish Kannabhiran, Rishi Arora, Pratap Reddy, Rakesh Gopinathannair
Europace. 2018-01-01 - 79 citationsDifferences in complication rates between large bore needle and a long micropuncture needle during epicardial access: time to change clinical practice?Sampath Gunda, Madhu Reddy, Jayasree Pillarisetti, Moustapha Atoui, Nitish Badhwar
Circulation. Arrhythmia and Electrophysiology. 2015-08-01
Press Mentions
- New Data Available for Minimally Invasive Treatment of AFibNovember 19th, 2024
- Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and at-Risk Population Awareness GapsSeptember 14th, 2022
- Better Organized Care for AF Patients Presenting in ERs Helps Improve Outcomes and LOSMay 2nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: